Altogether, these IHC results in an independent cohort of DLBCL samples validated the higher infiltration of CD68-positive cells and the increased expression of the inflammatory factor IRF8 in tumors compared with normal lymph nodes, and also highlighted a strong correlation between these markers. This evidence concerns the gene IRF8 and diffuse large B-cell lymphoma.